Skip to main content
  • Open-Label Study: Early Dapagliflozin Treatment Safe in Hospitalized Patients With Acute HF

    Guideline-direct medical therapy (GDMT) optimization is partially and safely met with early dapagliflozin treatment in hospitalized patients with acute heart failure (AHF), a new open-label study shows.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details